Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$53.9M |
| 2 |
COUP
Coupa Software Incorporated
COUP
|
+$32.1M |
| 3 |
COWN
Cowen Inc. Class A Common Stock
COWN
|
+$27.8M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$20.1M |
| 5 |
M&T Bank
MTB
|
+$20.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Y
Alleghany Corp
Y
|
+$93.4M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$71.8M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$42.9M |
| 4 |
ZEN
ZENDESK INC
ZEN
|
+$42.3M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$41.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.01% |
| 2 | Financials | 11.75% |
| 3 | Industrials | 10.85% |
| 4 | Healthcare | 10.32% |
| 5 | Consumer Discretionary | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
PUT
Huntington Bancshares
HBAN
$34.4B
| $260K | 0.01% |
+18,400
| New | +$266K |
|
2002
American Electric Power
AEP
$66.4B
| $258K | 0.01% |
2,720
-5,710
| -68% | -$520K |
|
2003
Avantor
AVTR
$9.64B
| $257K | 0.01% |
+12,182
| New | +$252K |
|
2004
PUT
Dover
DOV
$27.4B
| $257K | 0.01% |
1,900
-100
| -5% | -$13.3K |
|
|
SRG
2005
Seritage Growth Properties
SRG
$119M
| $257K | 0.01% |
+21,742
| New | +$241K |
|
|
GTM
2006
PUT
ZoomInfo Technologies
GTM
$1.14B
| $256K | 0.01% |
+8,500
| New | +$293K |
|
2007
RELX
RELX
$63.4B
| $255K | 0.01% |
9,190
-16,610
| -64% | -$447K |
|
|
SPR
2008
CALL
DELISTED
Spirit AeroSystems
SPR
| $255K | 0.01% |
8,600
-2,600
| -23% | -$67.5K |
|
2009
Digimarc Corp
DMRC
$135M
| $254K | 0.01% |
13,753
-10,251
| -43% | -$191K |
|
2010
PUT
Mercado Libre
MELI
$98.8B
| $254K | 0.01% |
+300
| New | +$267K |
|
2011
CALL
Polaris
PII
$3.66B
| $253K | 0.01% |
+2,500
| New | +$260K |
|
2012
CALL
Bath & Body Works
BBWI
$3.86B
| $252K | 0.01% |
6,000
-700
| -10% | -$26.1K |
|
|
HTBK
2013
DELISTED
Heritage Commerce
HTBK
| $252K | 0.01% |
19,360
-17,316
| -47% | -$233K |
|
2014
Regenxbio
RGNX
$531M
| $252K | 0.01% |
11,110
-2,791
| -20% | -$63.1K |
|
2015
Revolve Group
RVLV
$1.7B
| $252K | 0.01% |
11,307
-43,227
| -79% | -$1.04M |
|
|
VTLE
2016
CALL
DELISTED
Vital Energy
VTLE
| $252K | 0.01% |
4,900
+900
| +23% | +$55.6K |
|
2017
PUT
Assurant
AIZ
$14.2B
| $251K | 0.01% |
+2,000
| New | +$266K |
|
2018
CTS Corp
CTS
$1.6B
| $251K | 0.01% |
+6,373
| New | +$262K |
|
|
RPTX
2019
DELISTED
Repare Therapeutics
RPTX
| $251K | 0.01% |
+17,034
| New | +$255K |
|
2020
Brady Corp
BRC
$4.45B
| $249K | ﹤0.01% |
+5,280
| New | +$242K |
|
2021
PUT
CONMED
CNMD
$1.54B
| $249K | ﹤0.01% |
+2,800
| New | +$232K |
|
2022
Astec Industries
ASTE
$1B
| $246K | ﹤0.01% |
6,043
-10,577
| -64% | -$427K |
|
2023
CALL
Brinker International
EAT
$10.9B
| $246K | ﹤0.01% |
+7,700
| New | +$242K |
|
2024
Geron
GERN
$977M
| $246K | ﹤0.01% |
101,782
-9,843
| -9% | -$22.1K |
|
2025
CALL
Landstar System
LSTR
$6.11B
| $246K | ﹤0.01% |
+1,500
| New | +$241K |
|
Similar funds
Paul Tudor Jones's Q4 2022 Portfolio in Review
As of Q4 2022, Paul Tudor Jones held 3,056 positions worth $5.06B, up 9.2% from $4.63B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Paul Tudor Jones deployed $198M of net new capital in Q4 2022, opening 801 new positions and adding to 766 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 648,672 shares worth $73.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $39M trimmed.
- Paul Tudor Jones's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 648,672 shares worth $73.8M.
- Paul Tudor Jones added most to Coupa Software Incorporated in Q4 2022, an estimated $32.1M increase.
- Paul Tudor Jones's biggest Q4 2022 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $39M.
- Paul Tudor Jones fully exited Alleghany Corp in Q4 2022, selling an estimated $93.4M.
- Paul Tudor Jones's ten largest holdings make up 9.1% of its $5.06B portfolio in Q4 2022.
- Paul Tudor Jones opened 801 new positions and closed 756 in Q4 2022.
- Paul Tudor Jones's portfolio value rose 9.2% quarter-over-quarter to $5.06B.
Based on Tudor Investment Corp's 13F filing for Q4 2022, filed 14 Feb 2023.